.jpg?itok=W6nsHDXV)
Company search
RTW Biotech Opportunities has an additional market quote in sterling.
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 03/02/2025
In
Objective
To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
AIC sector
Management group
Company website
Launch date
29/10/2019
December
Domicile
Guernsey
Fund manager
Naveen Yalamanchi, Roderick Wong, Stephanie Sirota, Sabera Loughran
Dividend frequency
Data Not Available
Wind-up provisions
The Company has an unlimited life.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 459.93 | 607.64 | 1.37 | 1.81 | -24.31 | 0 | 0.00 | N/A | 1.87 (31/12/2023) |
Scroll
Note
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| RTW Biotech Opportunities | Share price total return | -1.8 | 0.7 | 1.1 | N/A |
| Biotechnology & Healthcare AIC sector | Share price total return | 1.1 | -3.8 | -3.7 | 63.1 |
Scroll
Share structure
Number of shares
335,713,649
10,253,791
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 167,333 | 3,673,846 | 120,496,230 | 226,495,343 |
| Average | N/A | 169,873 | 476,545 | 179,606 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.23 | 5.06 | 169.41 | 328.39 |
| Average | N/A | 0.23 | 0.67 | 0.26 |
Scroll
Trading details
Top holdings
Data as at : 30/06/2024
| Investment | % of total assets |
|---|---|
| Healthcare.com Inc Shs Stock Settlement | 26.9 |
| Others | 21.3 |
| Avidity Biosciences, Inc. | 13.2 |
| Rocket Pharmaceuticals Inc | 7.6 |
| Madrigal Pharmaceuticals Inc | 7.3 |
| Dyne Therapeutics Inc Ordinary Shares | 5.7 |
| Avidity Biosciences Inc Ordinary Shares | 5.4 |
| Artios Pharma Limited | 5.2 |
| Ji Xing Pharmaceuticals Ltd. | 5.0 |
| Others | 2.3 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
